CompBioJobs

Bioinformatics, Biostatistics & Computational Jobs in Pharma and Biotech

O

Oxford Nanopore Technologies

The Only Sensing Platform

Oxford, UK (US: Cambridge, MA & NYC)
1,200+

About Oxford Nanopore Technologies

Industry: Genomics
Founded: 2005
Founders: Hagan Bayley, Gordon Sanghera
Status: Public (LSE: ONT)

Funding & Growth

Total Raised: $1B+
Valuation: $3B+ market cap
Stage: Public
Key Investors:
IP Group Illumina (former) GV

Pros

  • Revolutionary nanopore technology
  • Real-time sequencing innovation
  • Portable/field sequencing leader
  • Rapid growth and innovation
  • Cutting-edge ML/basecalling

Cons

  • UK headquarters (timezone)
  • Smaller US presence
  • Competitive with Illumina/PacBio
  • Stock volatility